Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Digital envirotyping: quantifying environmental determinants of health and behavior.

Engelhard MM, Oliver JA, McClernon FJ.

NPJ Digit Med. 2020 Mar 12;3:36. doi: 10.1038/s41746-020-0245-3. eCollection 2020.

2.

Relationships between the Nicotine Metabolite Ratio and a Panel of Exposure and Effect Biomarkers: Findings from Two Studies of U.S. Commercial Cigarette Smokers.

Carroll DM, Murphy SE, Benowitz NL, Strasser AA, Kotlyar M, Hecht SS, Carmella SG, McClernon FJ, Pacek LR, Dermody SS, Vandrey RG, Donny EC, Hatsukami DK.

Cancer Epidemiol Biomarkers Prev. 2020 Feb 12. doi: 10.1158/1055-9965.EPI-19-0644. [Epub ahead of print]

PMID:
32051195
3.

Risk perceptions regarding cigarette smoking in the United States continue to decline.

Pacek LR, McClernon FJ.

Drug Alcohol Depend. 2020 Feb 5;209:107887. doi: 10.1016/j.drugalcdep.2020.107887. [Epub ahead of print]

PMID:
32044588
4.

The Impact of Gradual and Immediate Nicotine Reduction on Subjective Cigarette Ratings.

Smith TT, Donny EC, Luo X, Allen AM, Carroll DM, Denlinger-Apte RL, Dermody SS, Koopmeiners JS, McClernon FJ, Pacek LR, Vandrey R, Hatsukami DK.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S73-S80. doi: 10.1093/ntr/ntz158.

5.

Anticipated Effects of Nicotine Reduction on Youth Smoking Initiation and Maintenance.

Colby SM, Cassidy RN, Denlinger-Apte R, Smith TT, Pacek LR, McClernon FJ, Tidey JW.

Nicotine Tob Res. 2019 Dec 23;21(Suppl 1):S46-S48. doi: 10.1093/ntr/ntz101.

6.

Not quite the rule, but no longer the exception: multiple tobacco product use and implications for treatment, research, and regulation.

Pacek LR, Villanti AC, McClernon FJ.

Nicotine Tob Res. 2019 Dec 2. pii: ntz221. doi: 10.1093/ntr/ntz221. [Epub ahead of print]

PMID:
31789377
7.
8.

Very low nicotine content cigarettes disrupt the feedback loop of affective states and smoking behavior.

Robinson JD, Kypriotakis G, al'Absi M, Denlinger-Apte RL, Drobes DJ, Leischow S, McClernon FJ, Pacek LR, Severson H, Smith TT, Donny EC, Luo X, Jensen JA, Strayer LG, Cinciripini PM, Hatsukami DK.

Nicotine Tob Res. 2019 Nov 8. pii: ntz209. doi: 10.1093/ntr/ntz209. [Epub ahead of print]

PMID:
31701153
9.

Pilot Randomized Controlled Trial of a Novel Smoking Cessation App Designed for Individuals with Co-Occurring Tobacco Dependence and Serious Mental Illness.

Vilardaga R, Rizo J, Palenski P, Mannelli P, Oliver JA, McClernon FJ.

Nicotine Tob Res. 2019 Oct 31. pii: ntz202. doi: 10.1093/ntr/ntz202. [Epub ahead of print]

PMID:
31667501
10.

Smoking abstinence effects on emotion dysregulation in adult cigarette smokers with and without attention-deficit/hyperactivity disorder.

Mitchell JT, McClernon FJ, Beckham JC, Brown RA, Lejuez CW, Kollins SH.

Drug Alcohol Depend. 2019 Dec 1;205:107594. doi: 10.1016/j.drugalcdep.2019.107594. Epub 2019 Sep 27.

PMID:
31639512
11.

Graphic Warning Labels Affect Hypothetical Cigarette Purchasing Behavior among Smokers Living with HIV.

Pacek LR, Berry MS, Rass O, Mercincavage M, McClernon FJ, Johnson MW.

Int J Environ Res Public Health. 2019 Sep 12;16(18). pii: E3380. doi: 10.3390/ijerph16183380.

12.

Identifying Smoking Environments From Images of Daily Life With Deep Learning.

Engelhard MM, Oliver JA, Henao R, Hallyburton M, Carin LE, Conklin C, McClernon FJ.

JAMA Netw Open. 2019 Aug 2;2(8):e197939. doi: 10.1001/jamanetworkopen.2019.7939.

13.

Young adult dual combusted cigarette and e-cigarette users' anticipated responses to hypothetical e-cigarette market restrictions.

Pacek LR, Rass O, Sweitzer MM, Oliver JA, McClernon FJ.

Subst Use Misuse. 2019;54(12):2033-2042. doi: 10.1080/10826084.2019.1626435. Epub 2019 Jul 15.

PMID:
31305213
14.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

15.

Predicting Smoking Events with a Time-Varying Semi-Parametric Hawkes Process Model.

Engelhard M, Xu H, Carin L, Oliver JA, Hallyburton M, McClernon FJ.

Proc Mach Learn Res. 2018 Aug;85:312-331.

16.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

17.

Cannabinoid exposure and altered DNA methylation in rat and human sperm.

Murphy SK, Itchon-Ramos N, Visco Z, Huang Z, Grenier C, Schrott R, Acharya K, Boudreau MH, Price TM, Raburn DJ, Corcoran DL, Lucas JE, Mitchell JT, McClernon FJ, Cauley M, Hall BJ, Levin ED, Kollins SH.

Epigenetics. 2018;13(12):1208-1221. doi: 10.1080/15592294.2018.1554521. Epub 2018 Dec 18.

18.

Formative, multimethod case studies of learn to quit, an acceptance and commitment therapy smoking cessation app designed for people with serious mental illness.

Vilardaga R, Rizo J, Ries RK, Kientz JA, Ziedonis DM, Hernandez K, McClernon FJ.

Transl Behav Med. 2019 Nov 25;9(6):1076-1086. doi: 10.1093/tbm/iby097.

PMID:
30445507
19.

Young adult dual combusted cigarette and e-cigarette users' anticipated responses to a nicotine reduction policy and menthol ban in combusted cigarettes.

Pacek LR, Oliver JA, Sweitzer MM, McClernon FJ.

Drug Alcohol Depend. 2019 Jan 1;194:40-44. doi: 10.1016/j.drugalcdep.2018.10.005. Epub 2018 Oct 26.

20.

Correlates of support for a nicotine-reduction policy in smokers with 6-week exposure to very low nicotine cigarettes.

Denlinger-Apte RL, Tidey JW, Koopmeiners JS, Hatsukami DK, Smith TT, Pacek LR, McClernon FJ, Donny EC.

Tob Control. 2019 May;28(3):352-355. doi: 10.1136/tobaccocontrol-2018-054622. Epub 2018 Nov 1.

PMID:
30385649
21.

Smartphone-Based Contingency Management Intervention to Improve Pre-Exposure Prophylaxis Adherence: Pilot Trial.

Mitchell JT, LeGrand S, Hightow-Weidman LB, McKellar MS, Kashuba AD, Cottrell M, McLaurin T, Satapathy G, McClernon FJ.

JMIR Mhealth Uhealth. 2018 Sep 10;6(9):e10456. doi: 10.2196/10456.

22.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

23.

A Conceptual Framework for Understanding Multiple Tobacco Product Use and the Impact of Regulatory Action.

Pacek LR, Wiley JL, McClernon FJ.

Nicotine Tob Res. 2019 Feb 18;21(3):268-277. doi: 10.1093/ntr/nty129. Review.

24.

Age Moderates Smokers' Subjective Response to Very-Low Nicotine Content Cigarettes: Evidence from a Randomized Controlled Trial.

Cassidy RN, Tidey JW, Cao Q, Colby SM, McClernon FJ, Koopmeiners JS, Hatsukami D, Donny EC.

Nicotine Tob Res. 2019 Jun 21;21(7):962-969. doi: 10.1093/ntr/nty079.

25.

Perceived risk of developing smoking-related disease among persons living with HIV.

Pacek LR, McClernon FJ, Rass O, Sweizter MM, Johnson MW.

AIDS Care. 2018 Oct;30(10):1329-1334. doi: 10.1080/09540121.2018.1466985. Epub 2018 Apr 22.

26.

Whether to push or pull? Nicotine reduction and non-combusted alternatives - Two strategies for reducing smoking and improving public health.

Smith TT, Hatsukami DK, Benowitz NL, Colby SM, McClernon FJ, Strasser AA, Tidey JW, White CM, Donny EC.

Prev Med. 2018 Dec;117:8-14. doi: 10.1016/j.ypmed.2018.03.021. Epub 2018 Mar 29.

27.

Using Neuroscience to Inform Tobacco Control Policy.

Maynard OM, McClernon FJ, Oliver JA, Munafò MR.

Nicotine Tob Res. 2019 May 21;21(6):739-746. doi: 10.1093/ntr/nty057.

28.

The Effects of Nicotine and Tobacco Use on Brain Reward Function: Interaction With Nicotine Dependence Severity.

Addicott MA, Sweitzer MM, McClernon FJ.

Nicotine Tob Res. 2019 May 21;21(6):764-771. doi: 10.1093/ntr/nty059.

29.

Effects of reduced nicotine content cigarettes on individual withdrawal symptoms over time and during abstinence.

Dermody SS, McClernon FJ, Benowitz N, Luo X, Tidey JW, Smith TT, Vandrey R, Hatsukami D, Donny EC.

Exp Clin Psychopharmacol. 2018 Jun;26(3):223-232. doi: 10.1037/pha0000179. Epub 2018 Mar 5.

30.

Decline in the perceived risk of cigarette smoking between 2006 and 2015: Findings from a U.S. nationally representative sample.

Pacek LR, McClernon FJ.

Drug Alcohol Depend. 2018 Apr 1;185:406-410. doi: 10.1016/j.drugalcdep.2018.01.002.

31.

Perceptual Characterization of the Macronutrient Picture System (MaPS) for Food Image fMRI.

King JL, Fearnbach SN, Ramakrishnapillai S, Shankpal P, Geiselman PJ, Martin CK, Murray KB, Hicks JL, McClernon FJ, Apolzan JW, Carmichael OT.

Front Psychol. 2018 Jan 26;9:17. doi: 10.3389/fpsyg.2018.00017. eCollection 2018.

32.

Combined Smoking Cues Enhance Reactivity and Predict Immediate Subsequent Smoking.

Conklin CA, McClernon FJ, Vella EJ, Joyce CJ, Salkeld RP, Parzynski CS, Bennett L.

Nicotine Tob Res. 2019 Jan 4;21(2):241-248. doi: 10.1093/ntr/nty009.

33.

Precision medicine in addiction research: where has the time gone?

Oliver JA, McClernon FJ.

Addiction. 2017 Dec;112(12):2096-2097. doi: 10.1111/add.14023. No abstract available.

PMID:
29105925
34.

What Do Smokers Want in A Smartphone-Based Cessation Application?

Oliver JA, Hallyburton MB, Pacek LR, Mitchell JT, Vilardaga R, Fuemmeler BF, McClernon FJ.

Nicotine Tob Res. 2018 Nov 15;20(12):1507-1514. doi: 10.1093/ntr/ntx171.

35.

Adherence to Pharmacological Smoking Cessation Interventions: A Literature Review and Synthesis of Correlates and Barriers.

Pacek LR, McClernon FJ, Bosworth HB.

Nicotine Tob Res. 2018 Sep 4;20(10):1163-1172. doi: 10.1093/ntr/ntx210. Review.

36.

ADHD, Smoking Withdrawal, and Inhibitory Control: Results of a Neuroimaging Study with Methylphenidate Challenge.

Sweitzer MM, Kollins SH, Kozink RV, Hallyburton M, English J, Addicott MA, Oliver JA, McClernon FJ.

Neuropsychopharmacology. 2018 Mar;43(4):851-858. doi: 10.1038/npp.2017.248. Epub 2017 Oct 20.

37.

Childhood ADHD Symptoms and Future Illicit Drug Use: The Role of Adolescent Cigarette Use.

Lee CT, McClernon FJ, Kollins SH, Fuemmeler BF.

J Pediatr Psychol. 2018 Mar 1;43(2):162-171. doi: 10.1093/jpepsy/jsx098.

38.

Association Between Baseline Corticothalamic-Mediated Inhibitory Control and Smoking Relapse Vulnerability.

Froeliger B, McConnell PA, Bell S, Sweitzer M, Kozink RV, Eichberg C, Hallyburton M, Kaiser N, Gray KM, McClernon FJ.

JAMA Psychiatry. 2017 Apr 1;74(4):379-386. doi: 10.1001/jamapsychiatry.2017.0017.

39.

Use and Perceived Risk of Electronic Cigarettes Among North Carolina Middle and High School Students.

Giovacchini CX, Pacek L, McClernon FJ, Que LG.

N C Med J. 2017 Jan-Feb;78(1):7-13. doi: 10.18043/ncm.78.1.7.

40.

Smoking environment cues reduce ability to resist smoking as measured by a delay to smoking task.

Stevenson JG, Oliver JA, Hallyburton MB, Sweitzer MM, Conklin CA, McClernon FJ.

Addict Behav. 2017 Apr;67:49-52. doi: 10.1016/j.addbeh.2016.12.007. Epub 2016 Dec 18.

41.

A Pilot Trial Examining African American and White Responses to Algorithm-Guided Smoking Cessation Medication Selection in Persons Living with HIV.

Valera P, McClernon FJ, Burkholder G, Mugavero MJ, Willig J, O'Cleirigh C, Cropsey KL.

AIDS Behav. 2017 Jul;21(7):1975-1984. doi: 10.1007/s10461-016-1634-0.

42.

Reducing nicotine exposure results in weight gain in smokers randomised to very low nicotine content cigarettes.

Rupprecht LE, Koopmeiners JS, Dermody SS, Oliver JA, al'Absi M, Benowitz NL, Denlinger-Apte R, Drobes DJ, Hatsukami D, McClernon FJ, Pacek LR, Smith TT, Sved AF, Tidey J, Vandrey R, Donny EC.

Tob Control. 2017 Mar;26(e1):e43-e48. doi: 10.1136/tobaccocontrol-2016-053301. Epub 2016 Nov 17.

43.

Implicit Attitudes and Smoking Behavior in a Smoking Cessation Induction Trial.

Lee HS, Addicott M, Martin LE, Harris KJ, Goggin K, Richter KP, Patten CA, McClernon FJ, Fleming K, Catley D.

Nicotine Tob Res. 2017 Dec 13;20(1):58-66. doi: 10.1093/ntr/ntw259.

44.

Evaluation of a reduced nicotine product standard: Moderating effects of and impact on cannabis use.

Pacek LR, Vandrey R, Dermody SS, Denlinger-Apte RL, Lemieux A, Tidey JW, McClernon FJ, Bangdiwala AS, Drobes DJ, al'Absi M, Strasser AA, Koopmeiners JS, Hatsukami DK, Donny EC.

Drug Alcohol Depend. 2016 Oct 1;167:228-32. doi: 10.1016/j.drugalcdep.2016.08.620. Epub 2016 Aug 28.

45.

"I Use Weed for My ADHD": A Qualitative Analysis of Online Forum Discussions on Cannabis Use and ADHD.

Mitchell JT, Sweitzer MM, Tunno AM, Kollins SH, McClernon FJ.

PLoS One. 2016 May 26;11(5):e0156614. doi: 10.1371/journal.pone.0156614. eCollection 2016.

46.

Smoking Abstinence-Induced Changes in Resting State Functional Connectivity with Ventral Striatum Predict Lapse During a Quit Attempt.

Sweitzer MM, Geier CF, Addicott MA, Denlinger R, Raiff BR, Dallery J, McClernon FJ, Donny EC.

Neuropsychopharmacology. 2016 Sep;41(10):2521-9. doi: 10.1038/npp.2016.56. Epub 2016 Apr 19.

47.

Non-cigarette tobacco and poly-tobacco use among persons living with HIV drawn from a nationally representative sample.

Pacek LR, Sweitzer MM, McClernon FJ.

Drug Alcohol Depend. 2016 May 1;162:251-5. doi: 10.1016/j.drugalcdep.2016.03.020. Epub 2016 Mar 30.

48.

Blunted striatal response to monetary reward anticipation during smoking abstinence predicts lapse during a contingency-managed quit attempt.

Sweitzer MM, Geier CF, Denlinger R, Forbes EE, Raiff BR, Dallery J, McClernon FJ, Donny EC.

Psychopharmacology (Berl). 2016 Mar;233(5):751-60. doi: 10.1007/s00213-015-4152-2. Epub 2015 Dec 11.

49.

The fMRI BOLD response to unisensory and multisensory smoking cues in nicotine-dependent adults.

Cortese BM, Uhde TW, Brady KT, McClernon FJ, Yang QX, Collins HR, LeMatty T, Hartwell KJ.

Psychiatry Res. 2015 Dec 30;234(3):321-7. doi: 10.1016/j.pscychresns.2015.10.008. Epub 2015 Oct 9.

50.

Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, McClernon FJ, Montoya ID, Murphy SE, Robinson JD, Stitzer ML, Strasser AA, Tindle H, Hatsukami DK.

N Engl J Med. 2015 Oct;373(14):1340-9. doi: 10.1056/NEJMsa1502403.

Supplemental Content

Loading ...
Support Center